What Blood Test Tests for Prostate Cancer? A Guide

The primary blood test for prostate cancer is the prostate-specific antigen (PSA) test. This simple blood draw measures PSA levels, a protein produced by the prostate gland. Elevated levels may indicate prostate cancer, but other conditions can also raise PSA. Today, the PSA test remains the cornerstone of prostate cancer screening in the US, though newer blood-based tests like the 4Kscore and PHI are gaining use for risk assessment.

How the PSA Blood Test Works

What Is PSA?

Prostate-specific antigen (PSA) is a protein made by both normal and cancerous prostate cells. The test quantifies the amount of PSA circulating in your blood. While no single threshold definitively diagnoses cancer, a PSA level above 4.0 ng/mL has historically prompted further investigation. However, many men with levels below 4.0 still have cancer, and many with higher levels do not.

The Testing Process

A healthcare provider draws a blood sample from a vein, typically in your arm. The sample is sent to a lab for analysis. Results usually return within a few days. No special preparation is needed, though some medications and recent ejaculation or prostate exams can affect levels.

Interpreting PSA Results

Results are reported in nanograms per milliliter (ng/mL). The following table shows common reference ranges, though interpretation varies by age and health.

Age-specific ranges, PSA velocity (rate of change over time), and free-to-total PSA ratio provide additional context. Your doctor will interpret results based on your individual profile.

Limitations of the PSA Test

• False positives: Elevated PSA can result from benign prostatic hyperplasia (BPH), prostatitis, or recent activities like cycling or sexual activity.
• False negatives: Some men with prostate cancer have normal PSA levels, especially in early-stage or slow-growing cancers.
• Overdiagnosis: PSA may detect indolent cancers that would never cause symptoms, leading to unnecessary biopsies and treatments.
• No definitive cutoff: There is no single PSA value that perfectly separates cancer from benign conditions.

Additional Blood Tests for Prostate Cancer )

4Kscore Test

The 4Kscore combines four kallikrein markers (total PSA, free PSA, intact PSA, and human kallikrein 2) with clinical information to estimate the risk of aggressive prostate cancer. It reduces unnecessary biopsies by identifying men with a low probability of high-grade disease.

Prostate Health Index (PHI)

The PHI uses total PSA, free PSA, and [-2]proPSA to calculate a score. It is FDA-approved for men with PSA between 4.0 and 10.0 ng/mL and a normal digital rectal exam. A higher PHI score indicates greater risk of prostate cancer.

PCA3 Urine Test (Not Blood)

While not a blood test, the PCA3 urine test is often used alongside blood markers. It measures PCA3 gene expression after a digital rectal exam and helps decide whether a biopsy is needed.

Screening Guidelines currently

The US Preventive Services Task Force (USPSTF) recommends shared decision-making for men aged 55–69. The American Cancer Society suggests discussing screening starting at age 50 for average-risk men, and at 40–45 for those with a family history or African American heritage. Today, newer blood tests like 4Kscore and PHI are increasingly used to refine risk before biopsy.

If you’re considering prostate cancer screening, a simple blood test can provide crucial insights. At anylabtests.com, we offer convenient, affordable PSA testing and advanced prostate health panels. Take control of your health today.

Order your PSA blood test now and get results you can trust.